Metformin for the Treatment of Diabetes in Pregnancy

NCT ID: NCT00414245

Last Updated: 2006-12-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Diabetes Mellitus Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

metformin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant women
* GDM A2
* diabetes mellitus type 2
* singleton pregnancy

Exclusion Criteria

* diabetic nephropathy or proliferative retinopathy
* cannot swallow tablets
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ben-Gurion University of the Negev

OTHER

Sponsor Role collaborator

Soroka University Medical Center

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boaz Sheizaf, MD

Role: PRINCIPAL_INVESTIGATOR

division of obstetrics and gynecology, soroka university medical center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Division of Obstetrics and Gynecology, Soroka University Medical Center

Beersheba, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Boaz Sheizaf, MD

Role: CONTACT

Phone: 972-54-2401191

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Boaz Sheizaf, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

sor434306ctil

Identifier Type: -

Identifier Source: org_study_id